Deutsch
 
Mein Konto  

ANMELDEN & VORTEILE SICHERN

  • Preise & Rabatte einsehen
  • Geschenke sichern
  • Angebote anfragen & online annehmen
JETZT ANMELDEN Noch nicht registriert? Konto hier erstellen!
Vergleich
Ergebnisse

Ergebnisse filtern

Typ
Specific against
Host
Clone
  1. 1(23)
  2. 10(9)
  3. 10C12(4)
  4. 10F.9G2(23)
  5. 116-13.1(10)
  6. 11B11(20)
  7. 12G5(5)
  8. 14-4-4S(10)
  9. 145-2C11(19)
  10. 15(9)
  11. 15-3-1S(4)
  12. 15A7(4)
  13. 16-10A1(19)
  14. 178 (LALAPG)(5)
  15. 17A2(8)
  16. 18B12(7)
  17. 1a3(5)
  18. 1A8(19)
  19. 1D11.1(5)
  20. 1D11.16.8(10)
  21. 1D3(14)
  22. 1F6(9)
  23. 1G9(26)
  24. 1H1(6)
  25. 2(23)
  26. 2.4G2(19)
  27. 20D5(14)
  28. 20H2(5)
  29. 225(4)
  30. 22D1(19)
  31. 24(5)
  32. 29E.2A3(16)
  33. 29F.1A12(19)
  34. 2D5(10)
  35. 2D5-1.9(9)
  36. 2H7(19)
  37. 3(28)
  38. 30-H12(19)
  39. 33D1(40)
  40. 37(9)
  41. 38(5)
  42. 38/42(4)
  43. 384-35(5)
  44. 3E8#(4)
  45. 3G8(15)
  46. 3H10.1(19)
  47. 3H3(19)
  48. 4(5)
  49. 43(9)
  50. 480(14)
  51. 4A9(18)
  52. 4E1.2(9)
  53. 4LO3311(18)
  54. 50-6(5)
  55. 500A2(20)
  56. 509F6(8)
  57. 51(9)
  58. 53-5.8(19)
  59. 53-6.7(19)
  60. 55R-170(15)
  61. 55R-593(15)
  62. 5C8(3)
  63. 5G11(11)
  64. 6B11(5)
  65. 7B10(15)
  66. 7E.17G9(19)
  67. 7G7B6(19)
  68. 8C8(9)
  69. 9(5)
  70. 9000000000(10)
  71. 927(18)
  72. 9a2(9)
  73. 9D9(19)
  74. 9E9(8)
  75. 9H10(23)
  76. A4C8.1-Do9(10)
  77. A7R34(6)
  78. Abituzumab(3)
  79. Abrilumab(3)
  80. Aducanumab(3)
  81. AF6-88.5(9)
  82. Afasevikumab(3)
  83. AFS98(19)
  84. ALF-161(10)
  85. Amatuximab(3)
  86. Anifrolumab(3)
  87. Anrukinzumab(3)
  88. Apamistamab(3)
  89. Aprutumab(3)
  90. Atezolizumab(3)
  91. Atibuclimab(3)
  92. Avelumab(3)
  93. Avizakimab(3)
  94. B122(10)
  95. B22/249(14)
  96. B6H12(21)
  97. B7/21(5)
  98. B8-24-3(14)
  99. B8.2C12(5)
  100. Bamlanivimab(3)
  101. Bapineuzumab(3)
  102. Basiliximab(3)
  103. Batoclimab(3)
  104. Bavbio(5)
  105. Bavituximab(3)
  106. BC8(19)
  107. BE29G1(15)
  108. Begelomab(3)
  109. Belantamab(3)
  110. Belimumab(3)
  111. Bemarituzumab(3)
  112. Bermekimab(3)
  113. Bersanlimab(3)
  114. Bertilimumab(3)
  115. Bevacizumab(3)
  116. Bexmarilimab(3)
  117. Bimekizumab(3)
  118. Bivatuzumab(3)
  119. Bleselumab(3)
  120. Blosozumab(3)
  121. Bococizumab(3)
  122. Brazikumab(3)
  123. Brentuximab(3)
  124. Briakinumab(3)
  125. Brodalumab(3)
  126. Burosumab(3)
  127. BVD6-24G2(4)
  128. C1.18.4(11)
  129. C17.8(7)
  130. C71/16(16)
  131. C9B7W(18)
  132. Cadbio(5)
  133. Camidanlumab(3)
  134. Camrelizumab(3)
  135. Canakinumab(3)
  136. Caplacizumab(7)
  137. Carlumab(3)
  138. CD28.2(7)
  139. Cedelizumab(3)
  140. Cemiplimab(3)
  141. Cendakimab(3)
  142. Cetuximab(3)
  143. CHK-166(10)
  144. CHK152(5)
  145. Cibbio(5)
  146. Cixutumumab(3)
  147. Clazakizumab(3)
  148. Clenoliximab(3)
  149. Clervonafusp Alfa(4)
  150. Clesrovimab(3)
  151. Codrituzumab(3)
  152. Coltuximab(3)
  153. Cusatuzumab(3)
  154. CXCR3-173(18)
  155. Cy34.1(22)
  156. D12(4)
  157. D5(10)
  158. Dacetuzumab(3)
  159. Daclizumab(3)
  160. Daratumumab(3)
  161. DATK32(15)
  162. Daxdilimab(3)
  163. DC101(14)
  164. Dectrekumab(3)
  165. Denintuzumab(3)
  166. Denosumab(3)
  167. DREG56(5)
  168. Dupilumab(3)
  169. Durvalumab(3)
  170. Dusigitumab(3)
  171. E18(10)
  172. Edrecolomab(3)
  173. Efalizumab(3)
  174. EGFR.1(14)
  175. Eldelumab(3)
  176. Elipovimab(3)
  177. Elotuzumab(3)
  178. Emapalumab(3)
  179. Emibetuzumab(3)
  180. Enfortumab(3)
  181. Enibarcimab(3)
  182. Enoblituzumab(3)
  183. Enokizumab(3)
  184. Epratuzumab(5)
  185. Eptinezumab(3)
  186. Erenumab(3)
  187. ERIC-1(11)
  188. Erlizumab(3)
  189. Etaracizumab(3)
  190. Etokimab(3)
  191. Etrolizumab(3)
  192. Evinacumab(3)
  193. Evolocumab(3)
  194. Faralimomab(3)
  195. Farletuzumab(3)
  196. Fasinumab(3)
  197. FD441.8(15)
  198. Felzartamab(3)
  199. Fezakinumab(3)
  200. FGK4.5(19)
  201. FIB21(9)
  202. FIB27(3)
  203. FIB504(24)
  204. Ficlatuzumab(3)
  205. Figitumumab(3)
  206. Fletikumab(3)
  207. Fontolizumab(3)
  208. Foralumab(3)
  209. FR70(11)
  210. Fremanezumab(3)
  211. Fresolimumab(3)
  212. Frunevetmab(3)
  213. Fulranumab(3)
  214. G11(5)
  215. G28.5(19)
  216. G8.8(14)
  217. Galcanezumab(3)
  218. Gantenerumab(3)
  219. Gatralimab(3)
  220. Gemtuzumab(3)
  221. Gevokizumab(3)
  222. Giloralimab(3)
  223. Gimsilumab(3)
  224. GIR 208(9)
  225. Girentuximab(3)
  226. GK1.5(19)
  227. GL1(14)
  228. GL113(3)
  229. Glembatumumab(3)
  230. Grebio(5)
  231. Guselkumab(3)
  232. H22(20)
  233. H57-597(14)
  234. HB-14(7)
  235. HDB-4A7(9)
  236. HEK/1/85a/7a(18)
  237. HK1.4(10)
  238. HK2.1(15)
  239. HK5.3(15)
  240. HKSP(10)
  241. HKSP84(10)
  242. HM48-1(17)
  243. I21/7(15)
  244. I3/2.3(10)
  245. Ibalizumab(3)
  246. ICRF44(5)
  247. Ieramilimab(3)
  248. Ifibio(5)
  249. Ifinatamab(3)
  250. IK22/5(9)
  251. IM7(19)
  252. Indusatumab(3)
  253. Infliximab(3)
  254. Inolimomab(3)
  255. Intetumumab(3)
  256. Ipilimumab(3)
  257. Iratumumab(3)
  258. Isatuximab(3)
  259. Iscalimab(3)
  260. Itepekimab(3)
  261. Itolizumab(3)
  262. Ivuxolimab(3)
  263. Ixekizumab(3)
  264. J43(4)
  265. JAMA-147(10)
  266. JES5-2A5(4)
  267. JES6-1A12(5)
  268. JES6-5H4(4)
  269. Keliximab(3)
  270. L243(10)
  271. Lacnotuzumab(3)
  272. Lebrikizumab(3)
  273. Lemzoparlimab(3)
  274. Lenzilumab(3)
  275. Lerdelimumab(3)
  276. Lintuzumab(3)
  277. LO-CD2a(4)
  278. Lucatumumab(3)
  279. Lulizumab(3)
  280. Lumiliximab(3)
  281. Lusvertikimab(3)
  282. M1/69(8)
  283. M1/70(15)
  284. M290(4)
  285. M5/114.15.2(18)
  286. M5/49.4.1(10)
  287. Magrolimab(3)
  288. MAR 18.5(18)
  289. MAR1-5A3(19)
  290. Margetuximab(3)
  291. Matuzumab(3)
  292. Mavrilimumab(3)
  293. MB22-11(14)
  294. MD5-1(15)
  295. MECA-367(14)
  296. MECA-89(10)
  297. MEL-14(15)
  298. Metelimumab(3)
  299. Mezagitamab(3)
  300. MFL3(18)
  301. MIB-5E9.1(5)
  302. MIG-2F5-5(18)
  303. Minretumomab(3)
  304. Mirikizumab(3)
  305. Mirvetuximab(3)
  306. Mitazalimab(3)
  307. MJ18(18)
  308. MJ7/18(8)
  309. Monalizumab(3)
  310. Motavizumab(3)
  311. MP1-22E9(19)
  312. MP4-25D2(7)
  313. MP5-20F3(4)
  314. MPC-11(10)
  315. MR1(4)
  316. Mupadolimab(3)
  317. Muromonab(3)
  318. N418(5)
  319. Nadunolimab(3)
  320. Namilumab(3)
  321. Naratuximab(3)
  322. Natalizumab(3)
  323. Naxitamab(3)
  324. Necitumumab(3)
  325. Nemolizumab(3)
  326. Nerelimomab(3)
  327. Nesvacumab(3)
  328. Netakimab(3)
  329. Nipocalimab(3)
  330. Nivolumab(3)
  331. Obexelimab(3)
  332. Ocaratuzumab(3)
  333. Odulimomab(3)
  334. Ofatumumab(3)
  335. OKT-4(19)
  336. OKT10(19)
  337. Oleclumab(3)
  338. Olokizumab(3)
  339. Omalizumab(3)
  340. Omburtamab(3)
  341. Onvatilimab(3)
  342. Otelixizumab(3)
  343. Otilimab(3)
  344. OX-26(18)
  345. OX-7(18)
  346. OX-86(19)
  347. OX-90(18)
  348. Ozanezumab(3)
  349. Ozuriftamab(3)
  350. P84(9)
  351. Palivizumab(3)
  352. Pamrevlumab(3)
  353. Panitumumab(3)
  354. Parsatuzumab(3)
  355. Pascolizumab(3)
  356. Patbio(5)
  357. Pateclizumab(3)
  358. Patritumab(3)
  359. PC61(14)
  360. Pembrolizumab(3)
  361. Penpulimab(3)
  362. Perakizumab(3)
  363. Pertuzumab(3)
  364. Pinatuzumab(3)
  365. Pivekimab(3)
  366. PK136(19)
  367. Polatuzumab(3)
  368. Ponezumab(3)
  369. Ponsegromab(3)
  370. PS/2(18)
  371. Quetmolimab(3)
  372. R1-2(3)
  373. R4-6A2(12)
  374. RA3-6B2(19)
  375. Ramucirumab(3)
  376. Ravagalimab(3)
  377. RB6-8C5(19)
  378. Relatlimab(3)
  379. RG9-1(18)
  380. Rilotumumab(3)
  381. Ripertamab(3)
  382. Rituximab(5)
  383. RM134L(14)
  384. RM27-3E5(23)
  385. RMP1-14(26)
  386. RMP1-14-mAbMods(5)
  387. RMP1-14-mAbMods (D265A)(5)
  388. RMP1-14-mAbMods (LALA-PG)(5)
  389. RMP1-30(6)
  390. RMT1-10(14)
  391. RMT3-23(10)
  392. RMT4-53(10)
  393. Robatumumab(3)
  394. Rolinsatamab(3)
  395. Romosozumab(3)
  396. Rontalizumab(3)
  397. Rosopatamab(3)
  398. Rovalpituzumab(3)
  399. Rozanolixizumab(3)
  400. Sabatolimab(3)
  401. Sacituzumab(3)
  402. Sarilumab(3)
  403. Satralizumab(3)
  404. Secukinumab(3)
  405. Selicrelumab(3)
  406. Sifalimumab(3)
  407. Siltuximab(3)
  408. Simtuzumab(3)
  409. Sintilimab(3)
  410. Siplizumab(3)
  411. Sirukumab(3)
  412. SJ25-C1(6)
  413. Sofituzumab(3)
  414. Sotigalimab(3)
  415. Spesolimab(3)
  416. Sutimlimab(3)
  417. Suvizumab(3)
  418. T24/31(19)
  419. T29/33(5)
  420. T3-3A1(5)
  421. T56/14(5)
  422. TA-99(10)
  423. Tabalumab(3)
  424. Tadocizumab(3)
  425. Tafasitamab(3)
  426. Talbio(5)
  427. TAN1-7(19)
  428. Tanezumab(3)
  429. Tecbio(5)
  430. Teneliximab(3)
  431. Teplizumab(3)
  432. Teprotumumab(3)
  433. Tezepelumab(3)
  434. TIF-3C5(9)
  435. Tilavonemab(3)
  436. Tilvestamab(3)
  437. Tinurilimab(3)
  438. Tiragolumab(3)
  439. Tislelizumab(3)
  440. TKS-1(18)
  441. TN3-19.12(19)
  442. Tocilizumab(3)
  443. Toripalimab(3)
  444. Tositumomab(3)
  445. Tovetumab(3)
  446. TR75-54.7(15)
  447. Tralokinumab(3)
  448. Trastuzumab(3)
  449. Tregalizumab(3)
  450. TRFK5(14)
  451. Tusamitamab(3)
  452. TY/23(25)
  453. TY25(9)
  454. Ublituximab(3)
  455. UC10-4F10-11(19)
  456. UC3-10A6(15)
  457. UC7-13D5(10)
  458. UCHL-1(5)
  459. UCHM-1(5)
  460. UCHT-1(10)
  461. UCHT-2(5)
  462. UCHT-4(5)
  463. Uliledlimab(3)
  464. Upifitamab(3)
  465. Urabrelimab(3)
  466. Urelumab(3)
  467. Ustekinumab(3)
  468. Utomilumab(3)
  469. Vadastuximab(3)
  470. Vanalimab(3)
  471. Varisacumab(3)
  472. Varlilumab(3)
  473. Vatelizumab(3)
  474. Vedolizumab(3)
  475. Veltuzumab(3)
  476. Vibostolimab(3)
  477. Visilizumab(3)
  478. VL-4(10)
  479. Volociximab(3)
  480. Vunakizumab(3)
  481. W6/32(15)
  482. Xentuzumab(3)
  483. XMG1.2(19)
  484. Y-3(15)
  485. Y-3P(10)
  486. YN1/1.7.4(19)
  487. YTS-169(19)
  488. YTS191(18)
  489. Zagotenemab(3)
  490. Zalutumumab(3)
  491. Zanolimumab(3)
  492. Zilovertamab(3)
  493. Ziltivekimab(3)
  494. Zinlirvimab(3)
  495. Zolbetuximab(3)
  496. Zolimomab(3)
  497. ZV67(5)
Applications
Isotype
Hersteller

In Vivo Antibodies

13369 Artikel

pro Seite

Seite:
  1. 63
  2. 64
  3. 65
  4. 66
  5. 67
Name PDF Typ Clone Specific against Appl. Host ArtNr. Menge ✓ Preis
Trastuzumab Biosimilar -­ Research Grade Biosimilars Hu AFIM-ab-131-trastuzumab

AffinityImmuno 		500 ug Anmelden
Vergleichen
Ado-­trastuzumab emtansine Biosimilar -­ Research Grade Biosimilars Hu AFIM-ab-131-ado-trastuzumab

AffinityImmuno 		500 ug Anmelden
Vergleichen
Aflibercept Biosimilar -­ Research Grade Biosimilars Hu AFIM-ab-131-aflibercept

AffinityImmuno 		500 ug Anmelden
Vergleichen
Alirocumab Biosimilar -­ Research Grade Biosimilars Hu AFIM-ab-131-alirocumab

AffinityImmuno 		500 ug Anmelden
Vergleichen
Avelumab Biosimilar -­ Research Grade Biosimilars Hu AFIM-ab-131-avelumab

AffinityImmuno 		500 ug Anmelden
Vergleichen
Atezolizumab Biosimilar -­ Research Grade Biosimilars Hu AFIM-ab-131-atezolizumab

AffinityImmuno 		500 ug Anmelden
Vergleichen
Denosumab Biosimilar -­ Research Grade Biosimilars Hu AFIM-ab-131-denosumab

AffinityImmuno 		500 ug Anmelden
Vergleichen
Daratumumab Biosimilar -­ Research Grade Biosimilars Hu AFIM-ab-131-daratumumab

AffinityImmuno 		500 ug Anmelden
Vergleichen
Etanercept Biosimilar -­ Research Grade Biosimilars Hu AFIM-ab-131-etanercept

AffinityImmuno 		500 ug Anmelden
Vergleichen
Evolocumab Biosimilar -­ Research Grade Biosimilars Hu AFIM-ab-131-evolocumab

AffinityImmuno 		500 ug Anmelden
Vergleichen
Ipilimumab Biosimilar -­ Research Grade Biosimilars Hu AFIM-ab-131-ipilimumab

AffinityImmuno 		500 ug Anmelden
Vergleichen
Obinutuzumab Biosimilar -­ Research Grade Biosimilars Hu AFIM-ab-131-obinutuzumab

AffinityImmuno 		500 ug Anmelden
Vergleichen
Ofatumumab Biosimilar -­ Research Grade Biosimilars Hu AFIM-ab-131-ofatumumab

AffinityImmuno 		500 ug Anmelden
Vergleichen
Panitumumab Biosimilar -­ Research Grade Biosimilars Hu AFIM-ab-131-panitumumab

AffinityImmuno 		500 ug Anmelden
Vergleichen
Pembrolizumab Biosimilar -­ Research Grade Biosimilars Hu AFIM-ab-131-pembrolizumab

AffinityImmuno 		500 ug Anmelden
Vergleichen
Pertuzumab Biosimilar -­ Research Grade Biosimilars Hu AFIM-ab-131-pertuzumab

AffinityImmuno 		500 ug Anmelden
Vergleichen
Ranibizumab Biosimilar -­ Research Grade Biosimilars Hu AFIM-ab-131-ranibizumab

AffinityImmuno 		500 ug Anmelden
Vergleichen
Ramucirumab Biosimilar -­ Research Grade Biosimilars Hu AFIM-ab-131-ramucirumab

AffinityImmuno 		500 ug Anmelden
Vergleichen
Secukinumab Biosimilar -­ Research Grade Biosimilars Hu AFIM-ab-131-secukinumab

AffinityImmuno 		500 ug Anmelden
Vergleichen
Ustekinumab Biosimilar -­ Research Grade Biosimilars Hu AFIM-ab-131-ustekinumab

AffinityImmuno 		500 ug Anmelden
Vergleichen
Vedolizumab Biosimilar -­ Research Grade Biosimilars Hu AFIM-ab-131-vedolizumab

AffinityImmuno 		500 ug Anmelden
Vergleichen
Abx-­Ma1 Biosimilar -­ Anti-­CD146 mAb -­ Research Grade Biosimilars Hu Mammalian cells PX-TA1914-100

ProteoGenix 		100 ug Anmelden
Vergleichen
Mupadolimab Biosimilar -­ Anti-­CD73 mAb -­ Research Grade Biosimilars Other Mammalian cells PX-TA1755-100

ProteoGenix 		100 ug Anmelden
Vergleichen
Mupadolimab Biosimilar -­ Anti-­CD73 mAb -­ Research Grade Biosimilars Other Mammalian cells PX-TA1755-1MG

ProteoGenix 		1 mg Anmelden
Vergleichen
Theralizumab Biosimilar -­ Anti-­CD28 mAb -­ Research Grade Biosimilars Other Mammalian cells PX-TA1927-100

ProteoGenix 		100 ug Anmelden
Vergleichen
Name Preis
Trastuzumab Biosimilar -­ Research Grade Anmelden Trastuzumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 500 ug
Lieferbar
Ado-­trastuzumab emtansine Biosimilar -­ Research Grade Anmelden Ado-trastuzumab emtansine Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 500 ug
Lieferbar
Aflibercept Biosimilar -­ Research Grade Anmelden Aflibercept Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 500 ug
Lieferbar
Alirocumab Biosimilar -­ Research Grade Anmelden Alirocumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 500 ug
Lieferbar
Avelumab Biosimilar -­ Research Grade Anmelden Avelumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 500 ug
Lieferbar
Atezolizumab Biosimilar -­ Research Grade Anmelden Atezolizumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 500 ug
Lieferbar
Denosumab Biosimilar -­ Research Grade Anmelden Denosumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 500 ug
Lieferbar
Daratumumab Biosimilar -­ Research Grade Anmelden Daratumumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 500 ug
Lieferbar
Etanercept Biosimilar -­ Research Grade Anmelden Etanercept Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 500 ug
Lieferbar
Evolocumab Biosimilar -­ Research Grade Anmelden Evolocumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 500 ug
Lieferbar
Ipilimumab Biosimilar -­ Research Grade Anmelden Ipilimumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 500 ug
Lieferbar
Obinutuzumab Biosimilar -­ Research Grade Anmelden Obinutuzumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 500 ug
Lieferbar
Ofatumumab Biosimilar -­ Research Grade Anmelden Ofatumumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 500 ug
Lieferbar
Panitumumab Biosimilar -­ Research Grade Anmelden Panitumumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 500 ug
Lieferbar
Pembrolizumab Biosimilar -­ Research Grade Anmelden Pembrolizumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 500 ug
Lieferbar
Pertuzumab Biosimilar -­ Research Grade Anmelden Pertuzumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 500 ug
Lieferbar
Ranibizumab Biosimilar -­ Research Grade Anmelden Ranibizumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 500 ug
Lieferbar
Ramucirumab Biosimilar -­ Research Grade Anmelden Ramucirumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 500 ug
Lieferbar
Secukinumab Biosimilar -­ Research Grade Anmelden Secukinumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 500 ug
Lieferbar
Ustekinumab Biosimilar -­ Research Grade Anmelden Ustekinumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 500 ug
Lieferbar
Vedolizumab Biosimilar -­ Research Grade Anmelden Vedolizumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 500 ug
Lieferbar
Abx-­Ma1 Biosimilar -­ Anti-­CD146 mAb -­ Research Grade Anmelden Abx-Ma1 Biosimilar - Anti-CD146 mAb - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host Mammalian cells
ArtNr.
Menge 100 ug
Lieferbar
Mupadolimab Biosimilar -­ Anti-­CD73 mAb -­ Research Grade Anmelden Mupadolimab Biosimilar - Anti-CD73 mAb - Research Grade
Typ Biosimilars
Clone
Specific against Other
Appl.
Host Mammalian cells
ArtNr.
Menge 100 ug
Lieferbar
Mupadolimab Biosimilar -­ Anti-­CD73 mAb -­ Research Grade Anmelden Mupadolimab Biosimilar - Anti-CD73 mAb - Research Grade
Typ Biosimilars
Clone
Specific against Other
Appl.
Host Mammalian cells
ArtNr.
Menge 1 mg
Lieferbar
Theralizumab Biosimilar -­ Anti-­CD28 mAb -­ Research Grade Anmelden Theralizumab Biosimilar - Anti-CD28 mAb - Research Grade
Typ Biosimilars
Clone
Specific against Other
Appl.
Host Mammalian cells
ArtNr.
Menge 100 ug
Lieferbar

13369 Artikel

pro Seite

Seite:
  1. 63
  2. 64
  3. 65
  4. 66
  5. 67
Kontakt

Hölzel Diagnostika Handels GmbH
Weinsbergstr 118a
D-50823 Köln

T +49 221 126 02 66
F +49 221 126 02 67

info@hoelzel.de

Über Hölzel
Service
Infothek
Spendenaktion Datenschutzsiegel

Copyright 2025 Hölzel Diagnostika Handels GmbH

To top